• shareshare
  • link
  • cite
  • add
auto_awesome_motion View all 6 versions
Publication . Preprint . 2020

Evolution of outcomes for patients hospitalized during the first SARS-CoV-2 pandemic wave in France

Lefrancq, Noémie; Paireau, Juliette; Hozé, Nathanaël; Courtejoie, Noémie; Yazdanpanah, Yazdan; Bouadma, Lila; Boëlle, Pierre-Yves; +3 Authors
Published: 23 Sep 2020
Publisher: HAL CCSD
Country: France
As SARS-CoV-2 continues to spread, a thorough characterization of healthcare needs and patient outcomes is essential to inform planning; however, these analyses are complicated by ongoing changes in patient profiles. Here we develop age and sex adjusted models to analyze detailed patient trajectories from 91,304 hospitalizations in France during the first 4 months of the epidemic. Only 25% of hospital deaths occurred in patients that were admitted into ICU. The probability of entering ICU fell by 50% and the probability of death by 52% over the study period. Had the age and sex profile not changed over time, these reductions would have been 59% and 56%, respectively. These findings suggest substantial improvements in patient outcomes since the start of the pandemic.

SARS-CoV-2, COVID-19, epidemiology, hospital, ICU, outcome, delays, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie

20 references, page 1 of 2

1. T. Singhal, A Review of Coronavirus Disease-2019 (COVID-19). Indian J. Pediatr. 87, 281-286 (2020).

2. RECOVERY Collaborative Group, P. Horby, W. S. Lim, J. R. Emberson, M. Mafham, J. L. Bell, L. Linsell, N. Staplin, C. Brightling, A. Ustianowski, E. Elmahi, B. Prudon, C. Green, T. Felton, D. Chadwick, K. Rege, C. Fegan, L. C. Chappell, S. N. Faust, T. Jaki, K. Jeffery, A. Montgomery, K. Rowan, E. Juszczak, J. K. Baillie, R. Haynes, M. J. Landray, Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report. N. Engl. J. Med. (2020), doi:10.1056/NEJMoa2021436.

3. R. Verity, L. C. Okell, I. Dorigatti, P. Winskill, C. Whittaker, N. Imai, G. CuomoDannenburg, H. Thompson, P. G. T. Walker, H. Fu, A. Dighe, J. T. Griffin, M. Baguelin, S. Bhatia, A. Boonyasiri, A. Cori, Z. Cucunubá, R. FitzJohn, K. Gaythorpe, W. Green, A. Hamlet, W. Hinsley, D. Laydon, G. Nedjati-Gilani, S. Riley, S. van Elsland, E. Volz, H. Wang, Y. Wang, X. Xi, C. A. Donnelly, A. C. Ghani, N. M. Ferguson, Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect. Dis. 20, 669-677 (2020). [OpenAIRE]

4. P. N. Perez Guzman, A. Daunt, S. Mukherjee, P. Crook, R. Forlano, M. Kont, A. Lochen, M. Vollmer, P. Middleton, R. Judge, Others, Report 17: Clinical characteristics and predictors of outcomes of hospitalised patients with COVID-19 in a London NHS Trust: a retrospective cohort study, doi:10.25561/78613.

5. S. Richardson, J. S. Hirsch, M. Narasimhan, J. M. Crawford, T. McGinn, K. W. Davidson, and the Northwell COVID-19 Research Consortium, D. P. Barnaby, L. B. Becker, J. D. Chelico, S. L. Cohen, J. Cookingham, K. Coppa, M. A. Diefenbach, A. J. Dominello, J. Duer-Hefele, L. Falzon, J. Gitlin, N. Hajizadeh, T. G. Harvin, D. A. Hirschwerk, E. J. Kim, Z. M. Kozel, L. M. Marrast, J. N. Mogavero, G. A. Osorio, M. Qiu, T. P. Zanos, Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA (2020), doi:10.1001/jama.2020.6775.

6. J. A. Lewnard, V. X. Liu, M. L. Jackson, M. A. Schmidt, B. L. Jewell, J. P. Flores, C. Jentz, G. R. Northrup, A. Mahmud, A. L. Reingold, M. Petersen, N. P. Jewell, S. Young, J. Bellows, Incidence, clinical outcomes, and transmission dynamics of severe coronavirus disease 2019 in California and Washington: prospective cohort study. BMJ. 369, m1923 (2020). [OpenAIRE]

7. C. M. Petrilli, S. A. Jones, J. Yang, H. Rajagopalan, L. O'Donnell, Y. Chernyak, K. A. Tobin, R. J. Cerfolio, F. Francois, L. I. Horwitz, Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 369, m1966 (2020). [OpenAIRE]

8. C. Faes, S. Abrams, D. Van Beckhoven, G. Meyfroidt, E. Vlieghe, N. Hens, Time between Symptom Onset, Hospitalisation and Recovery or Death: a Statistical Analysis of Different Time-Delay Distributions in Belgian COVID-19 Patients. Epidemiology (2020), , doi:10.1101/2020.07.18.20156307.

9. H. Salje, C. Tran Kiem, N. Lefrancq, N. Courtejoie, P. Bosetti, J. Paireau, A. Andronico, N. Hozé, J. Richet, C.-L. Dubost, Y. Le Strat, J. Lessler, D. Levy-Bruhl, A. Fontanet, L. Opatowski, P.-Y. Boelle, S. Cauchemez, Estimating the burden of SARS-CoV-2 in France. Science. 369, 208-211 (2020).

10. S. Joebges, N. Biller-Andorno, Ethics guidelines on COVID-19 triage-an emerging

Funded by
Versatile Emerging infectious disease Observatory
  • Funder: European Commission (EC)
  • Project Code: 874735
  • Funding stream: H2020 | RIA
Coupling dynamic population immunity profiles and host behaviours to arboviral spread
  • Funder: European Commission (EC)
  • Project Code: 804744
  • Funding stream: H2020 | ERC | ERC-STG
Institut Convergences pour l’étude de l’Emergence des Pathologies au Travers des Individus et des populatiONs
  • Funder: French National Research Agency (ANR) (ANR)
  • Project Code: ANR-16-CONV-0005
Related to Research communities